PMC:7443692 / 1184-1431 JSONTXT

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T6","span":{"begin":132,"end":142},"obj":"Species"},{"id":"T7","span":{"begin":196,"end":201},"obj":"Species"}],"attributes":[{"id":"A6","pred":"ncbi_taxonomy_id","subj":"T6","obj":"NCBItxid:2697049"},{"id":"A7","pred":"ncbi_taxonomy_id","subj":"T7","obj":"NCBItxid:9606"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":" to inhibit viral infection.\n\nGraphical Abstract\n\nHighlights\n• Site-specific N-linked microheterogeneity is defined at 22 sites of SARS-CoV-2 Spike\n• Six sites of N-linked microheterogeneity of human ACE2 receptor are described\n• Molecular dyna"}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T9","span":{"begin":30,"end":48},"obj":"Sentence"},{"id":"T10","span":{"begin":50,"end":60},"obj":"Sentence"},{"id":"T11","span":{"begin":61,"end":148},"obj":"Sentence"},{"id":"T12","span":{"begin":149,"end":229},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" to inhibit viral infection.\n\nGraphical Abstract\n\nHighlights\n• Site-specific N-linked microheterogeneity is defined at 22 sites of SARS-CoV-2 Spike\n• Six sites of N-linked microheterogeneity of human ACE2 receptor are described\n• Molecular dyna"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T3","span":{"begin":12,"end":27},"obj":"Disease"},{"id":"T4","span":{"begin":132,"end":142},"obj":"Disease"}],"attributes":[{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0005108"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":" to inhibit viral infection.\n\nGraphical Abstract\n\nHighlights\n• Site-specific N-linked microheterogeneity is defined at 22 sites of SARS-CoV-2 Spike\n• Six sites of N-linked microheterogeneity of human ACE2 receptor are described\n• Molecular dyna"}

{"project":"LitCovid-sample-UniProt","denotations":[{"id":"T277","span":{"begin":202,"end":206},"obj":"Protein"}],"attributes":[{"id":"A277","pred":"uniprot_id","subj":"T277","obj":"https://www.uniprot.org/uniprot/Q9UFZ6"}],"text":" to inhibit viral infection.\n\nGraphical Abstract\n\nHighlights\n• Site-specific N-linked microheterogeneity is defined at 22 sites of SARS-CoV-2 Spike\n• Six sites of N-linked microheterogeneity of human ACE2 receptor are described\n• Molecular dyna"}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T6","span":{"begin":18,"end":27},"obj":"http://purl.obolibrary.org/obo/IDO_0000586"},{"id":"T7","span":{"begin":64,"end":68},"obj":"http://purl.obolibrary.org/obo/BFO_0000029"},{"id":"T8","span":{"begin":123,"end":128},"obj":"http://purl.obolibrary.org/obo/BFO_0000029"},{"id":"T9","span":{"begin":156,"end":161},"obj":"http://purl.obolibrary.org/obo/BFO_0000029"}],"text":" to inhibit viral infection.\n\nGraphical Abstract\n\nHighlights\n• Site-specific N-linked microheterogeneity is defined at 22 sites of SARS-CoV-2 Spike\n• Six sites of N-linked microheterogeneity of human ACE2 receptor are described\n• Molecular dyna"}

{"project":"LitCovid-sample-PD-GO-BP-0","denotations":[{"id":"T4","span":{"begin":12,"end":27},"obj":"http://purl.obolibrary.org/obo/GO_0016032"}],"text":" to inhibit viral infection.\n\nGraphical Abstract\n\nHighlights\n• Site-specific N-linked microheterogeneity is defined at 22 sites of SARS-CoV-2 Spike\n• Six sites of N-linked microheterogeneity of human ACE2 receptor are described\n• Molecular dyna"}

{"project":"LitCovid-sample-GO-BP","denotations":[{"id":"T4","span":{"begin":12,"end":27},"obj":"http://purl.obolibrary.org/obo/GO_0016032"}],"text":" to inhibit viral infection.\n\nGraphical Abstract\n\nHighlights\n• Site-specific N-linked microheterogeneity is defined at 22 sites of SARS-CoV-2 Spike\n• Six sites of N-linked microheterogeneity of human ACE2 receptor are described\n• Molecular dyna"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T25","span":{"begin":12,"end":17},"obj":"NCBITaxon:10239"},{"id":"T26","span":{"begin":132,"end":142},"obj":"SP_7"},{"id":"T27","span":{"begin":196,"end":201},"obj":"SP_6;NCBITaxon:9606;PG_10"},{"id":"T28","span":{"begin":202,"end":206},"obj":"PG_10;PR:000003622"}],"text":" to inhibit viral infection.\n\nGraphical Abstract\n\nHighlights\n• Site-specific N-linked microheterogeneity is defined at 22 sites of SARS-CoV-2 Spike\n• Six sites of N-linked microheterogeneity of human ACE2 receptor are described\n• Molecular dyna"}